Mylan's Generic Oracea Infringes Galderma IP: Judge
By Abigail Rubenstein · August 26, 2011, 7:47 PM EDT
A Delaware federal judge on Friday found that Mylan Pharmaceuticals Inc.'s efforts to bring a generic version of the rosacea drug Oracea to the market infringed a valid patent held by...
To view the full article, register now.